Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

BACKGROUND: An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why th...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	2005

Documenti analoghi

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
di: Green, A, et al.
Pubblicazione: (2005)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
di: Abhinav Mathur, et al.
Pubblicazione: (2022-11-01)

Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
di: N. T. Weerasinghe, et al.
Pubblicazione: (2021-12-01)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
di: Jumoke Okikiolu, et al.
Pubblicazione: (2023-01-01)

Polycythaemia vera and central sleep apnoea.
di: Stradling, JR, et al.
Pubblicazione: (1980)

Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera
di: Laith Al-Azrai, et al.
Pubblicazione: (2021-07-01)

Profile of polycythaemia vera in South Western Nigeria
di: Patrick Olanrewaju Osho, et al.
Pubblicazione: (2022-01-01)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients
di: Sergio Cabibbo, et al.
Pubblicazione: (2024-10-01)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
di: Pavai Sthaneshwar, et al.
Pubblicazione: (2023-10-01)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
di: ELMustafa Abdalla, et al.
Pubblicazione: (2022-06-01)

The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
di: M U Nwagu
Pubblicazione: (2011-01-01)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis
di: McMullin, M, et al.
Pubblicazione: (2018)

Study of JAK2V617F gene allele burden in polycythemia vera
di: F. Khalilova, et al.
Pubblicazione: (2020-10-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
di: Lewis Carpenter, et al.
Pubblicazione: (2022-08-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
di: Shanti Amé, et al.
Pubblicazione: (2023-08-01)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
di: Chartsiam Tipgomut, et al.
Pubblicazione: (2021-11-01)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
di: McMullin, M, et al.
Pubblicazione: (2018)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
di: Bee, P.C., et al.
Pubblicazione: (2010)

Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
di: Cilomar Martins De Oliveira Filho, et al.
Pubblicazione: (2022-01-01)

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
di: Susanne Schnittger, et al.
Pubblicazione: (2009-03-01)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
di: Beer, P, et al.
Pubblicazione: (2008)

PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
di: Yun Hui Hwang, et al.
Pubblicazione: (2023-08-01)

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
di: Sabina I. Swierczek, et al.
Pubblicazione: (2011-05-01)

Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation
di: Hui-Xin Shen, et al.
Pubblicazione: (2021-05-01)

Polyglobulia Masquerading as Polycythaemia Vera Presenting as Superior Mesenteric Vein Thrombosis: A Case Report
di: Janhavi Nitin Mahajan, et al.
Pubblicazione: (2022-10-01)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
di: Miguel Piris-Villaespesa, et al.
Pubblicazione: (2021-01-01)

PB2178: EVALUATION OF JAK2 EXON 12 MUTATIONS IN PATIENTS WITH JAK2 (V617F)-NEGATIVE POLYCYTHEMIA VERA
di: Sahar Khosravi, et al.
Pubblicazione: (2023-08-01)

Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
di: Beer, P, et al.
Pubblicazione: (2007)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
di: Robinson, SE, et al.
Pubblicazione: (2007)

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
di: Wilkins, B, et al.
Pubblicazione: (2008)

Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values
di: Richard T. Silver, et al.
Pubblicazione: (2019-11-01)

JAK2 p.V617F Variants in Non-Blood DNA from Patients with Polycythemia Vera
di: Naoki Mori, et al.
Pubblicazione: (2023-08-01)

Absence of JAK2 V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis
di: Stephen E. Langabeer
Pubblicazione: (2022-12-01)

JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
di: Bárbara da Costa Reis Monte-Mór, et al.
Pubblicazione: (2007-03-01)

Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases
di: Sreethish Sasi, et al.
Pubblicazione: (2021-01-01)

Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia
di: Harrison, C, et al.
Pubblicazione: (2014)

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
di: Harrison, C, et al.
Pubblicazione: (2014)

Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
di: Deepti Mutreja, et al.
Pubblicazione: (2014-08-01)

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
di: Emil Kuriakose, et al.
Pubblicazione: (2012-04-01)

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation
di: Mégane Brusson, et al.
Pubblicazione: (2017-07-01)